Impact Biomedical (IBO) Net Margin (2022 - 2026)
Impact Biomedical (IBO) recorded Net Margin of -3071.43% in Q3 2026, up 5095.24 percentage points from -8166.67% a year earlier and up 20228.57 percentage points from the prior quarter.
Powered by 
Analysis
Impact Biomedical (IBO) Net Margin (2022 - 2026) Analysis & Trends
On a TTM basis, Impact Biomedical's Net Margin came in at 4247.37% as of Sep 30, 2026, up 146798.98 percentage points year-over-year; for FY2025, it was -36993.75%, up 153067.79 percentage points from FY2024.
- Annual Net Margin has a three-year change of -22891.75 percentage points (FY2022 to FY2025).
- Across earlier years, Net Margin came in at -190061.54% in FY2024 (-156707.69 pp), -33353.85% in FY2023 (-19251.85 pp) and -14102.00% in FY2022.
- Quarterly Net Margin has ranged from -903600.00% in Q4 2024 to 141566.67% in Q3 2024 over the past five years.
- On a year-over-year basis, Net Margin has increased for four consecutive quarters, with an average year-over-year change of -2851.79 percentage points over the last eight quarters.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 978528.57 percentage points in Q4 2025, against a drop of 862433.33 percentage points in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -23300.00% (Q2 2026), -32671.43% (Q1 2026) and 74928.57% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 19.55% |
| 10 | Impact Biomedical | 43.92 Mn | 47.11 Mn | 15,000.00 | -3,071.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -3,071.43% |
| Jun 30, 2026 | -23,300.00% |
| Mar 31, 2026 | -32,671.43% |
| Dec 31, 2025 | 74,928.57% |
| Sep 30, 2025 | -8,166.67% |
| Jun 30, 2025 | -204,942.86% |
| Mar 31, 2025 | -42,233.33% |
| Dec 31, 2024 | -903,600.00% |
| Sep 30, 2024 | 141,566.67% |
| Jun 30, 2024 | -29,633.33% |
| Mar 31, 2024 | -32,066.67% |
| Dec 31, 2023 | -41,166.67% |
| Sep 30, 2023 | -38,733.33% |
| Jun 30, 2022 | -1,464.00% |
API Access
Impact Biomedical Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();